A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
暂无分享,去创建一个
K. Mansfield | S. Brem | D. O’Rourke | B. Levine | C. June | J. Melenhorst | M. Martinez-Lage | S. Mohan | H. Okada | J. Brogdon | M. Nasrallah | M. Maus | J. Morrissette | Zhaohui Zheng | S. Lacey | A. Shen | G. Plesa | A. Desai | J. Navenot | R. Isaacs | E. Maloney